Congressman blames Trump team for ending telehealth Medicare benefit. That’s not quite right.

Rep. Ro Khanna (D-Calif.) posted a Tiktok video on Feb. 20 saying he had “breaking news” about the fate of Medicare coverage for telehealth visits, which allow patients to see health care providers remotely from their homes.

Editas Medicine pads runway with $50M upfront from Vertex for Cas9 license

As Editas Medicine attempts to catch up to the historic approval of Vertex Pharmaceuticals and CRISPR Therapeutics’ gene-edited sickle cell treatment, the biotech will get

December 14, 2023

Karuna Therapeutics files for FDA approval for schizophrenia treatment – Pharmaceutical Technology

KarXT is providing a novel approach to treatment by not directly blocking dopamine receptors. Credit: Soloveva Anastasiia via www.shutterstock.com. Karuna Therapeutics has announced the submission

September 29, 2023

Novo Nordisk’s move to discontinue an insulin leaves patients to ‘pick up the pieces’

A year ago, when Novo Nordisk announced it would cut the price of multiple insulin products by up to 75%, President Biden, lawmakers, and patient

April 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.